167 related articles for article (PubMed ID: 38001699)
1. Ring Chromosomes in Hematological Malignancies Are Associated with
Boyd RJ; Murry JB; Morsberger LA; Klausner M; Chen S; Gocke CD; McCallion AS; Zou YS
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001699
[TBL] [Abstract][Full Text] [Related]
2. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
[TBL] [Abstract][Full Text] [Related]
3. Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemia.
Bochtler T; Granzow M; Stölzel F; Kunz C; Mohr B; Kartal-Kaess M; Hinderhofer K; Heilig CE; Kramer M; Thiede C; Endris V; Kirchner M; Stenzinger A; Benner A; Bornhäuser M; Ehninger G; Ho AD; Jauch A; Krämer A;
Blood; 2017 Mar; 129(10):1333-1342. PubMed ID: 28119329
[TBL] [Abstract][Full Text] [Related]
4.
Alkhatabi H; Yasin EB; Mirza Z; Alserihi R; Felimban R; Elaimi A; Shaabad M; Alharbi L; Ahmed H; Alameer AM; Mathkoor AE; Barefah AS
Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328276
[TBL] [Abstract][Full Text] [Related]
5. Karyotypic complexity, TP53 pathogenic variants, and increased number of variants on Next-Generation Sequencing are associated with disease progression in a North American Adult T-Cell Leukemia/Lymphoma cohort.
Zhang X; Shi Y; Ramesh KH; Naeem R; Wang Y
Int J Lab Hematol; 2021 Aug; 43(4):651-657. PubMed ID: 33988304
[TBL] [Abstract][Full Text] [Related]
6. Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndromes are associated with complex karyotype, monosomal karyotype,
Wang N; Yuan L; Jing Y; Fan K; Jin H; Lv C; Wang L; Yu L
Leuk Lymphoma; 2021 Oct; 62(10):2466-2474. PubMed ID: 33904352
[TBL] [Abstract][Full Text] [Related]
7. Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia.
Becker H; Pfeifer D; Ihorst G; Pantic M; Wehrle J; Rüter BH; Bullinger L; Hackanson B; Germing U; Kuendgen A; Platzbecker U; Döhner K; Ganser A; Hagemeijer A; Wijermans PW; Döhner H; Duyster J; Lübbert M
Ann Hematol; 2020 Jul; 99(7):1551-1560. PubMed ID: 32504186
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
[TBL] [Abstract][Full Text] [Related]
9. Ring chromosome in myeloid neoplasms is associated with complex karyotype and disease progression.
Rosenbaum MW; Pozdnyakova O; Geyer JT; Dal Cin P; Hasserjian RP
Hum Pathol; 2017 Oct; 68():40-46. PubMed ID: 28842184
[TBL] [Abstract][Full Text] [Related]
10. Concurrent detection of targeted copy number variants and mutations using a myeloid malignancy next generation sequencing panel allows comprehensive genetic analysis using a single testing strategy.
Shen W; Szankasi P; Sederberg M; Schumacher J; Frizzell KA; Gee EP; Patel JL; South ST; Xu X; Kelley TW
Br J Haematol; 2016 Apr; 173(1):49-58. PubMed ID: 26728869
[TBL] [Abstract][Full Text] [Related]
11. A high prevalence of myeloid malignancies in progeria with Werner syndrome is associated with p53 insufficiency.
Kato H; Maezawa Y; Nishijima D; Iwamoto E; Takeda J; Kanamori T; Yamaga M; Mishina T; Takeda Y; Izumi S; Hino Y; Nishi H; Ishiko J; Takeuchi M; Kaneko H; Koshizaka M; Mimura N; Kuzuya M; Sakaida E; Takemoto M; Shiraishi Y; Miyano S; Ogawa S; Iwama A; Sanada M; Yokote K
Exp Hematol; 2022 May; 109():11-17. PubMed ID: 35240258
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular characteristics of acute myeloid leukemia and the dismal prognosis of
Liu H; Shi Y; Tao S; Li Y; Wang C; Yu L
Hematology; 2023 Dec; 28(1):2223866. PubMed ID: 37313982
[TBL] [Abstract][Full Text] [Related]
13. Clinical Utility of Targeted Next-Generation Sequencing Assay to Detect Copy Number Variants Associated with Myelodysplastic Syndrome in Myeloid Malignancies.
Jiang L; Pallavajjala A; Huang J; Haley L; Morsberger L; Stinnett V; Hardy M; Park R; Ament C; Finch A; Shane A; Parish R; Nozari A; Long P; Adams E; Smith K; Parimi V; Dougaparsad S; Long L; Gocke CD; Zou YS
J Mol Diagn; 2021 Apr; 23(4):467-483. PubMed ID: 33577993
[TBL] [Abstract][Full Text] [Related]
14. TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele.
Bacher U; Weissmann S; Kohlmann A; Schindela S; Alpermann T; Schnittger S; Kern W; Haferlach T; Haferlach C
Br J Haematol; 2012 Jan; 156(1):67-75. PubMed ID: 22017486
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics and therapeutic effect of TP53 variant in patients with acute leukemia].
Mi R; Guo Z; Liu W; Hu J; Fan R; Chen L; Liu J; Wei X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Oct; 38(10):955-960. PubMed ID: 34625931
[TBL] [Abstract][Full Text] [Related]
16. Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignancies.
Mukherjee S; Sathanoori M; Ma Z; Andreatta M; Lennon PA; Wheeler SR; Prescott JL; Coldren C; Casey T; Rietz H; Fasig K; Woodford R; Hartley T; Spence D; Donnelan W; Berdeja J; Flinn I; Kozyr N; Bouzyk M; Correll M; Ho H; Kravtsov V; Tunnel D; Chandra P
Cancer Genet; 2017 Oct; 216-217():128-141. PubMed ID: 29025587
[TBL] [Abstract][Full Text] [Related]
17. The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype.
Dicker F; Herholz H; Schnittger S; Nakao A; Patten N; Wu L; Kern W; Haferlach T; Haferlach C
Leukemia; 2009 Jan; 23(1):117-24. PubMed ID: 18843282
[TBL] [Abstract][Full Text] [Related]
18. TP53 mutations in myelodysplastic syndrome.
Misawa S; Horiike S
Leuk Lymphoma; 1996 Nov; 23(5-6):417-22. PubMed ID: 9031070
[TBL] [Abstract][Full Text] [Related]
19. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]